Related Experiment Videos
Impaired nitric oxide release by glomeruli from diabetic rats
P A Craven1, R K Studer, F R DeRubertis
1Department of Medicine, Veterans Affairs Medical Center, Pittsburgh, PA 15240, USA.
Metabolism: Clinical and Experimental
|June 1, 1995
Summary
Diabetic rats show impaired nitric oxide (NO) production in kidney glomeruli. This reduced NO generation correlates with diabetes-induced changes in glomerular function.
Area of Science:
- Nephrology
- Endocrinology
- Physiology
Background:
- Diabetes mellitus is associated with microvascular complications.
- Nitric oxide (NO) plays a crucial role in regulating renal hemodynamics and function.
- Dysregulation of NO production is implicated in diabetic nephropathy.
Purpose of the Study:
- To investigate basal and stimulated nitric oxide (NO) production in glomeruli from diabetic rats.
- To assess the impact of diabetes on NO generation and stability in the kidney glomerulus.
- To correlate NO production with previously observed changes in NO-dependent signaling.
Main Methods:
- Isolated glomeruli from diabetic and age-matched control rats were used.
- Nitric oxide (NO) production was measured using a NO-selective electrode.
- Stimulation of NO release was achieved using carbamylcholine (CCh) and the Ca2+ ionophore A23187.
- Spontaneous NO generation was assessed using s-nitrosopenicillamine (SNAP).
Main Results:
- Basal and stimulated NO production were significantly reduced in glomeruli from diabetic rats compared to controls.
- Both carbamylcholine (CCh) and A23187 elicited a markedly lower NO response in diabetic glomeruli.
- Spontaneous NO generation, measured with SNAP, was also impaired in the presence of diabetic glomeruli.
- These findings indicate a deficit in NO generation and/or stability in diabetic rat glomeruli.
Conclusions:
- Diabetes mellitus impairs nitric oxide (NO) generation and/or stability in rat kidney glomeruli.
- The observed reduction in NO production correlates with diabetes-induced suppression of NO-dependent cyclic guanosine 3',5'-monophosphate (cGMP).
- These alterations in NO signaling may contribute to the pathogenesis of diabetic nephropathy.